CJC-1295 DAC + Ipamorelin – 10mg

cjc-1295 ipamorelin 10mg research peptide uk — supplied as a high-purity lyophilized powder for laboratory research use only. Each vial is independently verified by third-party analytical testing (COA available) to confirm identity and purity. This material is intended solely for qualified researchers working in controlled laboratory environments.

CJC-1295 is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), modified with drug affinity complex (DAC) technology to extend its half-life. Ipamorelin is a selective growth hormone secretagogue peptide that stimulates the ghrelin receptor. When studied together, researchers examine the combined effects of these compounds on growth hormone secretion, pulsatility, and downstream IGF-1 production.

Preclinical investigations of cjc-1295 ipamorelin 10mg research peptide uk have included models exploring metabolism, recovery, and anabolic signaling pathways. Laboratory studies often focus on potential synergistic effects of pairing a GHRH analog with a GHRP (growth hormone–releasing peptide). Researchers also investigate pharmacokinetics, peptide stability, and hormone axis regulation in vitro and in vivo.

This product is not intended for human or veterinary use and must not be used for diagnostic or therapeutic purposes. It is supplied strictly for laboratory applications. This listing provides cjc-1295 ipamorelin 10mg research peptide uk with COA; research use only; UK supply only to qualified laboratories.